Nocardia is a genus of soil-dwelling bacteria responsible for a range of infections, from slowly progressive lung disease to brain abscesses and chronic skin wounds, that are notoriously difficult to diagnose. Most people will never encounter the name unless they or someone they know develops an infection while immunocompromised, but the organism itself is all around us, living in dirt and decaying plant material worldwide. What makes Nocardia especially tricky in clinical medicine is not its rarity so much as the ease with which it gets mistaken for tuberculosis, fungal infections, or cancer on imaging studies, sometimes delaying the correct diagnosis by weeks.
A Soil Bacterium With a Complicated Identity
Nocardia species are found in soil across every continent and in a range of climates, from temperate grasslands to semi-arid regions. One Iranian survey of over 800 soil samples recovered Nocardia from about one in five, with the highest isolation rates coming from soils with a mildly alkaline pH and from semi-nomadic, temperate climatic zones.1PubMed Central. Diversity and frequency of Nocardia spp. in the soil of Isfahan province, Iran People inhale Nocardia spores regularly without ever getting sick. The organism is classified as an opportunistic pathogen: it takes advantage of a weakened immune system rather than causing disease in otherwise healthy individuals.
The genus was named after Edmond Nocard, a French veterinarian who first described the bacterium in 1888 while investigating a cattle disease in Guadeloupe. Early microbiologists actually thought Nocardia was a fungus, because under the microscope its cells form long branching filaments that look fungal. It took decades and the advent of molecular tools to settle the question: Nocardia is firmly a bacterium, classified within the order Actinomycetales alongside relatives like Mycobacterium (the genus that includes the tuberculosis pathogen).2PubMed Central. Etymologia: Nocardia That family resemblance has practical consequences in the lab, which we’ll get to shortly.
How Nocardia Gets In and Stays In
Infection usually begins when a person inhales airborne Nocardia spores, which settle in the lungs. Less commonly, the bacteria enter through a break in the skin, such as a puncture wound, a thorn scratch, or even a surgical incision contaminated with soil.3PubMed. Transmission of nocardiosis and molecular typing of Nocardia species: a short review Once inside the body, the bacteria face the immune system’s first line of defense: neutrophils and macrophages, the white blood cells whose job is to engulf and destroy invaders. Nocardia has evolved remarkable tools to survive that encounter.
The two most studied weapons in Nocardia’s arsenal are the enzymes superoxide dismutase (SOD) and catalase. Neutrophils kill bacteria by flooding them with toxic oxygen-derived molecules, essentially a chemical blast. SOD and catalase neutralize those molecules. Classic experiments showed that a strain of Nocardia with roughly ten times more catalase than usual was nearly immune to killing by human neutrophils, while treating normal Nocardia cells with an antibody that blocked their surface SOD made them suddenly vulnerable, with neutrophils killing over half the cells.4PubMed Central. Role of superoxide dismutase and catalase as determinants of pathogenicity of Nocardia asteroides: importance in resistance to microbicidal activities of human polymorphonuclear neutrophils These enzymes essentially let Nocardia sit inside the very cells sent to kill it, surviving and even multiplying.5PubMed. Expression of Nocardia brasiliensis superoxide dismutase during the early infection of murine peritoneal macrophages
More recent genomic work has found that Nocardia species carry virulence-associated genes closely resembling those found in Mycobacterium tuberculosis, including genes experimentally verified to play roles in human tuberculosis.6PubMed Central. Genomic Virulence Features of Two Novel Species Nocardia barduliensis sp. nov. and Nocardia gipuzkoensis sp. nov., Isolated from Patients with Chronic Pulmonary Diseases This shared toolbox helps explain why the two organisms cause diseases that can look strikingly similar on a chest X-ray.
The Immune System’s Second Line of Defense
Because Nocardia can dodge innate immune cells, the body’s adaptive immune system becomes critical for clearing the infection. T lymphocytes, the same class of immune cell that fights TB, are the key players. Lab studies have demonstrated that T cells primed against Nocardia can bind directly to the bacterial cell wall and kill it, a relatively unusual feat for a lymphocyte. This killing was immunologically specific: T cells trained against one Nocardia species killed that species effectively but performed poorly or not at all against closely related species.7The Journal of Immunology. Immunologically specific direct T lymphocyte-mediated killing of Nocardia asteroides
This reliance on T cells is exactly why Nocardia infections cluster in people whose T-cell immunity is compromised, whether by organ transplant drugs, HIV, prolonged corticosteroid use, or cancer chemotherapy. The bacteria may also actively tilt the immune balance in their favor. In mouse models, Nocardia brasiliensis infection triggered an increase in regulatory T cells, a subset that suppresses immune activity, creating an immunosuppressive local environment that favors chronic infection.8PubMed Central. Nocardia brasiliensis induces an immunosuppressive microenvironment that favors chronic infection in BALB/c mice
Pulmonary Nocardiosis and Why It Mimics So Many Other Diseases
The lungs are the most common site of Nocardia infection. Symptoms are nonspecific and overlap heavily with pneumonia, tuberculosis, and even lung cancer: persistent cough (present in over 90% of cases in one series), fever, difficulty breathing, chest pain, and sometimes bloody sputum.9PLoS ONE. Clinical and Radiographic Characteristics of Pulmonary Nocardiosis: Clues to Earlier Diagnosis The most common risk factors in that same study were corticosteroid therapy (about two-thirds of patients), diabetes, and chronic lung disease.
Chest imaging does not make the diagnosis easy. CT scans typically show one or more lumps (nodules or masses) and patches of consolidation, the dense white areas that signal lung tissue full of fluid and inflammatory cells. Cavitation, where the center of a mass hollows out, is also common and occurs quickly, often within two weeks.10PLoS ONE. Clinical and Radiographic Characteristics of Pulmonary Nocardiosis: Clues to Earlier Diagnosis 11PubMed. CT findings of pulmonary nocardiosis One small detailed study found that cavitary nodules or masses appeared in two-thirds of patients, along with septal thickening and enlarged lymph nodes.12PubMed Central. The Findings of Pulmonary Nocardiosis on Chest High Resolution Computed Tomography: Single centre experience and review of literature All of these features also appear in tuberculosis, fungal infections, and malignancy, which is why nocardiosis is sometimes called “the great imitator” of the chest.
Spread Beyond the Lungs
Nocardia has a well-recognized tendency to spread from the lungs through the bloodstream, and when it does, it shows a striking preference for the brain. About 40% of patients with disseminated nocardiosis develop central nervous system involvement, a figure higher than most other bacterial infections.13Medical Principles and Practice. Clinical Characteristics and Treatment Outcome of Central Nervous System Nocardiosis: A Systematic Review of Reported Cases CNS nocardiosis most often takes the form of a brain abscess, and it can present with headaches, confusion, seizures, or focal neurological deficits depending on where the abscess forms. This tropism for neural tissue is one reason many clinicians order brain imaging even when a patient’s Nocardia infection appears limited to the lungs.
Skin and Eye Infections
Not all Nocardia infections start in the lungs. Cutaneous nocardiosis typically follows direct inoculation through a skin wound, often one contaminated with soil or plant material. It can present as an abscess, a draining sinus, or a persistent wound that fails to heal despite conventional treatment. In one reported case, a dormant Nocardia infection only became apparent after laser treatment of an old scar, requiring extended courses of trimethoprim-sulfamethoxazole (TMP-SMX) at high doses to resolve.14PubMed Central. Dormant cutaneous nocardiosis presenting as a nonhealing wound following laser treatment of a traumatic scar Some species, especially Nocardia brasiliensis, are well known for causing a lymphocutaneous pattern where infection spreads along lymphatic channels from the original wound, producing a chain of nodules up the arm or leg.
Ocular nocardiosis, though uncommon, deserves special attention because delayed diagnosis can threaten vision. Nocardia keratitis, an infection of the cornea, often follows an eye injury involving soil or plant matter, contact lens wear, or prior eye surgery. Symptoms include pain, light sensitivity, and lid swelling.15PubMed Central. Current diagnostic tools and management modalities of Nocardia keratitis A distinctive clue is a “wreath”-shaped pattern in the cornea, seen in roughly 40% of Nocardia keratitis cases in one 11-year review. That same study found that nearly half of keratitis patients had a history of eye exposure to soil or plant material. Nocardia scleritis (infection of the white of the eye) tended to show nodular lesions with pointed abscesses, and endophthalmitis (infection inside the eye) often presented with exudates around the pupil.16PubMed. Optimizing diagnosis and management of nocardia keratitis, scleritis, and endophthalmitis: 11-year microbial and clinical overview
Who Is Most at Risk
Nocardiosis overwhelmingly affects people with weakened immune systems. Solid organ transplant recipients are one of the highest-risk groups, and guidelines from the American Society of Transplantation note that nocardia infections have risen over the past two decades, partly because the pool of immunocompromised patients keeps growing and partly because labs have gotten better at detecting the organism.17PubMed. Nocardia infections in solid organ transplantation: Guidelines from the Infectious Diseases Community of Practice of the American Society of Transplantation The risk varies by transplant type and by the specific immunosuppressive drugs used.
Other high-risk groups include people on long-term corticosteroids, patients with HIV (especially those with very low CD4 counts), patients receiving cancer chemotherapy, and people with chronic lung diseases like COPD or bronchiectasis. Diabetes appears in many case series as an associated condition. Occasionally, though, Nocardia infects people without any clear immune deficiency, and certain species, particularly Nocardia brasiliensis causing skin infections in tropical regions, are capable of causing disease in immunocompetent hosts.
The Diagnostic Problem
One of the biggest challenges with nocardiosis is simply recognizing it. The organism grows slowly in the lab: cultures need to incubate for a minimum of two to three weeks before they can be called negative, and conventional methods for identifying the species can take one to three additional weeks after that.18PubMed Central. Nocardiosis: review of clinical and laboratory experience If the lab discards cultures too early, as sometimes happens in a busy clinical microbiology setting, the infection can be missed entirely.
Adding to the confusion, Nocardia and Mycobacterium (especially the tuberculosis bacillus) share enough traits to fool microbiologists. Both can grow on the same lab media, and both can stain acid-fast, meaning they retain dye in the same staining procedure used to diagnose TB. Young Nocardia cultures form long branching filaments that look distinctive, but as the culture ages, those filaments fragment into short bacilli and round cocci that can be mistaken for mycobacteria by a non-expert eye. The main lab clue that separates them is that only Nocardia produces aerial hyphae, wispy filaments that rise above the colony surface.19Revista do Instituto de Medicina Tropical de São Paulo. DIFFERENTIATION BETWEEN Nocardia spp. AND Mycobacterium spp.: CRITICAL ASPECTS FOR BACTERIOLOGICAL DIAGNOSIS
Modern Identification Tools
Molecular methods have dramatically improved the speed and accuracy of Nocardia identification. Gene sequencing, particularly of the 16S rRNA gene and other marker genes, is considered the gold standard. Newer approaches like MALDI-TOF mass spectrometry, a technique that identifies organisms by their protein fingerprint in minutes, have become workhorses in many clinical labs. One evaluation found that the latest MALDI-TOF databases achieved nearly 99% species-level accuracy for clinical Nocardia isolates.20PubMed Central. Application of MALDI-TOF mass spectrometry for identification of Nocardia species Another study using a supplemented in-house database alongside the commercial one reached about 96% correct species assignment.21PubMed. Identification of Nocardia species from clinical isolates using MALDI-TOF mass spectrometry Whole-genome sequencing and metagenomic next-generation sequencing are also emerging as tools, especially for complex cases where traditional methods fail.22PubMed. Species Identification And Antibiotic Susceptibility Testing Of The Nocardia Genus: Advances And Clinical Challenges
Getting to the correct species matters because different Nocardia species have very different antibiotic susceptibility profiles. An identification to genus level (“it’s Nocardia”) only gets you partway; the species name tells clinicians which drugs are likely to work.
Species Geography and Why It Matters Clinically
More than 100 Nocardia species have been described, but a handful dominate clinical infections. Which species you encounter depends heavily on where in the world you are. A large systematic review of Chinese clinical isolates found dramatic regional variation: N. cyriacigeorgica made up over a third of isolates in northern China, N. farcinica dominated in central China (about 40% of isolates), and N. brasiliensis was far more common in western China than eastern China.23PLOS Neglected Tropical Diseases. The species distribution and antimicrobial resistance profiles of Nocardia species in China: A systematic review and meta-analysis Similar geographic patterns appear worldwide, and they have practical consequences because each species carries a somewhat predictable pattern of drug resistance.24PubMed Central. Susceptibility profiles of Nocardia spp. to antimicrobial and antituberculotic agents detected by a microplate Alamar Blue assay
Treatment
The backbone of nocardiosis treatment is trimethoprim-sulfamethoxazole (TMP-SMX), the same antibiotic combination commonly used for urinary tract infections. Nocardia is susceptible to TMP-SMX in the vast majority of cases, and the drug has been the cornerstone of therapy for decades. For mild skin infections or non-severe pulmonary disease, TMP-SMX alone is often sufficient. For severe or disseminated infections, especially those involving the brain, clinicians add a second or third drug. The usual companions are amikacin (an intravenous aminoglycoside), imipenem (a carbapenem), or a third-generation cephalosporin.25PubMed. How do I manage nocardiosis?
One alternative that has gained attention is linezolid, to which Nocardia is almost always susceptible. Linezolid penetrates brain tissue well, making it valuable for CNS involvement, but its long-term use is limited by side effects including bone marrow suppression and nerve damage. Treatment durations are long compared to typical bacterial infections: about six months for most cases, and sometimes twelve months or longer for disseminated disease or ongoing immunosuppression. A multicenter retrospective study confirmed that TMP-SMX remained the treatment of choice and that combination regimens built around it yielded even better outcomes.26PubMed. Clinical characteristics, susceptibility profiles, and treatment of nocardiosis: a multicenter retrospective study in 2015-2021
Prevention in High-Risk Patients
There is no vaccine against Nocardia, and because the organism is everywhere in the environment, avoidance is impractical. The most effective preventive measure for transplant recipients and other high-risk patients is prophylactic TMP-SMX, which is already widely prescribed to prevent Pneumocystis pneumonia. A systematic review and individual patient data meta-analysis found that TMP-SMX prophylaxis reduced the risk of nocardiosis by about 70%, with an adjusted odds ratio of 0.3.27PubMed. Trimethoprim-sulfamethoxazole significantly reduces the risk of nocardiosis in solid organ transplant recipients: systematic review and individual patient data meta-analysis Even among the quarter of cases that broke through prophylaxis, nearly all isolates remained susceptible to TMP-SMX, suggesting that the drug still works when higher treatment doses are given.
A real-world problem arises when patients have a documented TMP-SMX allergy, since the alternative Pneumocystis prophylaxis drugs (like dapsone or atovaquone) do not protect against Nocardia. One study at a large transplant center found that among patients who developed nocardiosis while on alternative prophylaxis, a significant proportion could actually tolerate TMP-SMX when formally rechallenged. Of 20 patients who attempted rechallenge or desensitization, 80% tolerated the drug, and the remaining 20% experienced only mild, reversible side effects like rash.28Emerging Infectious Diseases. Nocardiosis in Immunocompromised Patients on Alternative Pneumocystis Prophylaxis This finding has prompted many transplant programs to more aggressively verify TMP-SMX allergy labels before accepting alternative regimens.
Nocardia in Animals
Nocardiosis is not exclusive to humans. The genus was originally discovered in cattle, and infections have been documented in dogs, cats, horses, fish, and marine mammals. In companion animals, the presentation can mirror the human pattern. A case report of two 14-week-old Dogue de Bordeaux puppies described acute limb lameness after traumatic skin wounds, followed by rapid dissemination to lymph nodes, lungs, kidneys, and brain, with multi-drug-resistant Nocardia farcinica identified at necropsy. Neither puppy had any known immune deficiency.29PubMed Central. Disseminated Nocardiosis Caused by Nocardia farcinica in Two Puppy Siblings In veterinary medicine as in human medicine, the challenge is thinking of Nocardia early enough: by the time cultures confirm the diagnosis after weeks of incubation, the infection may have spread widely. For pet owners, the practical takeaway is that deep or soil-contaminated wounds that fail to improve on standard antibiotics deserve a closer microbiological look, with cultures held long enough for slow growers to appear.